Monashee Investment Management »

Gossamer Bio shares owned by Monashee Investment Management

Quarter-by-quarter ownership of Gossamer Bio (GOSS) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in Gossamer Bio

Tip: Access up to 7 years of quarterly data

All positions including Gossamer Bio held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gossamer Bio by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.2M 3.5M 0.91
2023-09-30 $4.4M 5.3M 0.83
2022-09-30 $8.3M 694k 11.98
2019-03-31 $3.3M 150k 21.67

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Structure Therapeutics Sponsored Ads (GPCR)
Aercap Holdings Nv SHS (AER)
PG&E Corporation (PCG)
Korro Bio (KRRO)
Eyepoint Pharmaceuticals Com New (EYPT)
Celldex Therapeutics Com New (CLDX)
Roivant Sciences SHS (ROIV)

View all positions for Monashee Investment Management

Top funds holding Gossamer Bio

NEA Management Company
Artal Group
Vanguard Group
EcoR1 Capital
Octagon Capital Advisors
Arch Venture Corp
Citadel Advisors
Samsara BioCapital
Palo Alto Investors
Madison Avenue Partners
Hillhouse Capital Advisors
Millennium Management
Deutsche Bank Aktiengesellschaft
T. Rowe Price Associates
Monashee Investment Management

View all funds holding Gossamer Bio